Class & Mechanism — Thymosin Beta-4 (TB4) is a 43-amino acid peptide involved in actin regulation and cellular growth. It promotes cellular growth, stimulates blood cell development, and has been shown to repair damage to various organs, including the heart, skin, and ligaments.
Research-documented benefits — Local corpus: silent.
General-knowledge benefits — TB-500 is known for muscle repair, pain relief, and the promotion of wound healing. It has been investigated for its potential in tissue regeneration, particularly in the context of heart repair.
Typical injectable protocol — Research-only, experimental. Doses range from 2.0-2.5 mg injected subcutaneously twice a week for 4-6 consecutive weeks.
Key risks / contraindications — The excerpts do not report specific side effects, but individual responses to treatment may vary.
Bottom line — TB-500 is a promising peptide for tissue repair and regeneration, but its use is currently experimental and should be approached with caution.
References
- Antimicrobial Peptides and Human Disease
- Antimicrobial Peptides_ Basics for Clinical Application
- Antimicrobial peptides and the skin immune defense system
- Antimicrobial peptides from plants with potential against multidrug-resistant bacteria
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Click Chemistry_ A Universal Ligation Strategy
- GHK Peptide as a Natural Modulator of Multiple Cellular — Loren Pickart
- Handbook of Biologically Active Peptides
- Kosmetik für Ärzte und Apotheker
- Life Force
- Living a Fully Optimized Life
- Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
- Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
- Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
- Peptide Protocols Volume One — William A Seeds MD
- Peptide therapy with pentadecapeptide BPC 157 in traumatic — Gjurasin, Miroslav
- Rook's Textbook of Dermatology
- The effect of pentadecapeptide BPC 157, H-blockers — Predrag Sikiric
- The pharmacological properties of the novel peptide BPC 157 — P Sikiric（Affiliation Department of Pharmacology, Medical
- Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor